Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Ticker SymbolDGX
Company nameQuest Diagnostics Inc
IPO dateDec 17, 1996
CEODavis (James E)
Number of employees45000
Security typeOrdinary Share
Fiscal year-endDec 17
Address500 Plaza Drive
CitySECAUCUS
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07094
Phone19735202700
Websitehttps://www.questdiagnostics.com/
Ticker SymbolDGX
IPO dateDec 17, 1996
CEODavis (James E)